Wallen 1983.
Methods |
|
|
Participants | Inclusion criteria
Exclusion criteria
|
|
Interventions | Treatment group
Control group
|
|
Outcomes |
|
|
Notes |
|
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Random numbers table |
Allocation concealment (selection bias) | Unclear risk | Not reported |
Blinding (performance bias and detection bias) All outcomes | Unclear risk | Not reported |
Incomplete outcome data (attrition bias) All outcomes | High risk | At the 2‐4 day follow‐up, 6 girls were lost to follow‐up. By the 30‐40 day follow‐up, 10 girls were lost to follow‐up. |
Selective reporting (reporting bias) | Low risk | All planned outcomes were reported |
BUN ‐ blood urea nitrogen; CRP ‐ C‐reactive protein; ESR ‐ erythrocyte sedimentation rate; NS ‐ not stated; SCr ‐ serum creatinine; SMX ‐ sulfamethoxazole; TMP ‐ trimethoprim; UTI ‐ urinary tract infection